Niitsu Y, Watanabe N, Sone H, Neda H, Yamauchi N, Ohtsuka Y, Umeno H
Gan To Kagaku Ryoho. 1987 Jun;14(6 Pt 2):2089-97.
TNF is cytokine derived from macrophages and shows much promise for use in cancer therapy because of its marked antitumor effects and its high specificity to tumors. The clinical application (Phase I-II) of TNF has been started because human recombinant TNF (rH-TNF) can be produced on a large scale. In spite of notable antitumor effects, little is known concerning the mechanism of its cytotoxic action. In this article, the antitumor effects of rH-TNF against human and murine tumors, the mechanism of its action and the synergistic effects of rH-TNF in combination with IFN-gamma, various anticancer drugs or with hyperthermia are reviewed.
肿瘤坏死因子(TNF)是一种源自巨噬细胞的细胞因子,因其显著的抗肿瘤作用和对肿瘤的高特异性,在癌症治疗中具有很大的应用前景。由于可以大规模生产重组人肿瘤坏死因子(rH-TNF),其临床应用(I-II期)已经启动。尽管rH-TNF具有显著的抗肿瘤作用,但其细胞毒性作用机制仍知之甚少。本文综述了rH-TNF对人和小鼠肿瘤的抗肿瘤作用、其作用机制以及rH-TNF与γ干扰素、各种抗癌药物或热疗联合使用时的协同作用。